ScholarIQanswers from OpenAlex

Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors

PaperCitations, authors & open-access status

Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors have?

ScholarIQcitation count

Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors has 3,582 citations in the OpenAlex counts ScholarIQ stores.

When was Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors published?

ScholarIQyear

Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors has 2011 year in the ScholarIQ index.

What is the open-access status of Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors?

ScholarIQoa status

Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors has green oa status in the ScholarIQ index.

What is the DOI of Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors?

ScholarIQdoi

The DOI for Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors is on the source record.

What is the PMID of Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors?

ScholarIQpmid

The PMID for Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors is on the source record.

What is the OpenAlex record for Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors?

ScholarIQopenalex

The OpenAlex for Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial